This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Károly Acsai in Vascular Disease Treatment
Introduction: Károly Acsai, an accomplished inventor based in Budapest, Hungary, has made significant strides in the field of pharmacology. With a focus on developing innovative compounds, he has an impressive patent portfolio that highlights his commitment to improving medical therapies.
Latest Patents: Károly Acsai holds a patent for "Optically active pyridyl-4H-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases." This invention pertains to the compound (−)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine, emphasizing its therapeutic applications and the pharmaceutical compositions that incorporate these active ingredients. This advancement showcases his innovative approach to treating complex vascular conditions.
Career Highlights: Throughout his career, Károly Acsai has demonstrated a profound understanding of medicinal chemistry and its implications in regenerative therapies. His work not only enhances the treatment options available for patients suffering from vascular diseases but also sets a foundation for future research and development in this critical area of healthcare.
Collaborations: Károly has collaborated with notable peers, including Andrea Jednákovits and Lászió Ürögdi. Together, they have contributed to advancing scientific knowledge and practical applications in their fields, ensuring that their collective innovations push the boundaries of existing medical treatments.
Conclusion: Károly Acsai's contributions to science, particularly through his patent on an innovative derivative for treating vascular diseases, underscore his role as a leading inventor in the pharmaceutical industry. His ongoing work and collaborations are set to inspire future innovations that may yield groundbreaking treatments for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile